封面
市場調查報告書
商品編碼
1401768

非處方藥市場,按類型、配銷通路、國家和地區 - 2023-2030 年行業分析、市場規模、市場佔有率和預測

OTC Drugs Market, By Type, By Distribution channel, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030

出版日期: | 出版商: AnalystView Market Insights | 英文 297 Pages | 商品交期: 2-3個工作天內

價格

報告要點

2022 年非處方藥市場規模為 1,627.943 億美元,2023 年至 2030 年複合CAGR為 5.0%。

非處方藥市場-市場動態

製造商從處方分銷管道轉向非處方藥預計將推動市場需求

市場的突出趨勢之一是製造商從處方分銷管道轉向非處方藥。許多製造公司正在將其產品從處方藥轉向非處方藥。例如,拜耳公司在2019年年報中表示,作為其策略的一部分,該公司將把部分適合自我照護的處方產品改為非處方藥。預計這將導致新興國家和已開發國家針對各種疾病的這些分銷管道的可用性更高。市場的其他趨勢包括自有品牌非處方藥產品數量的增加。非處方藥產品線上銷售的成長以及自有品牌製造商和電子商務公司之間的合作正在形成市場新趨勢。例如,2019年9月,Dr. Reddy's Laboratories Ltd.宣佈在美國市場推出非處方藥奧美拉唑緩釋片。這些即將到來的新趨勢將使預測期內的市場成長多樣化。

非處方藥市場 - 關鍵見解

根據我們的研究分析師分享的分析,全球非處方藥市場預計在預測期內(2023-2030)每年將以 5.0% 左右的CAGR成長

由於製造商從處方分銷管道轉向非處方藥,非處方藥市場預計將以顯著的速度成長

根據類型,預計感冒和咳嗽細分市場將在 2022 年呈現最大市場佔有率

根據配銷通路,藥局和零售藥局是 2022 年的領先細分市場

按地區分類,北美是 2022 年的主要收入來源

非處方藥市場-細分分析:

全球非處方藥市場根據類型、配銷通路和地區進行細分。

根據類型,市場可分為鎮痛藥、感冒和咳嗽藥物、消化和腸道藥物、皮膚治療、維生素和礦物質等。由於季節性變化,人們中普通感冒和咳嗽的發生率不斷增加,預計感冒和咳嗽藥物領域將主導市場。據美國疾病管制與預防中心稱,感冒和咳嗽是 10 歲以下兒童和 65 歲以上老年人群中最常見的病症,這導致對治療產品的需求不斷增加。

根據配銷通路,市場分為藥局和零售藥房、醫院藥房和網路藥房。由於提供非處方藥產品的零售藥局數量不斷增加,以及患者對商店和零售藥局這些產品的偏好不斷增加,預計藥局和零售藥局部門在預測期內將佔據最大的市場佔有率。由於非處方藥分銷管道的增加和不同產品的供應,醫院藥房部門佔據了第二大市場佔有率。

非處方藥市場 - 地理洞察

從地理來看,該市場廣泛分佈於北美、拉丁美洲、歐洲、亞太地區以及中東和非洲地區。這些區域根據開展業務的國家進一步分類。

非處方藥市場-競爭格局:

在競爭激烈的非處方藥領域,製藥公司不斷創新,以擴大其產品組合併提高消費者的可及性。強生、拜耳和賽諾菲等主要企業正在策略性地從處方藥轉向非處方藥,從而增加全球針對各種健康狀況的自我保健藥物的供應。此外,由於線上銷售的增加以及自有品牌製造商和電子商務巨頭之間的合作夥伴關係的推動,自有品牌非處方藥產品的激增是一個新興趨勢。這一趨勢正在使市場格局多樣化,並為消費者提供更廣泛的自我藥療選擇。最近的合作和產品發布,例如MCKESSON CORPORATION 推出Foster & Thrive 品牌,以及RL Limited 與AFT Pharmaceuticals 合作進行線上OTC 銷售,反映了該行業致力於滿足不斷變化的患者需求並利用對無障礙醫療解決方案不斷成長的需求。

最近的發展:

2023 年 6 月,多元化製藥公司 MCKESSON CORPORATION 宣布推出 Foster & Thrive,這是一個精心策劃的 OTC 健康和保健產品自有品牌,以滿足不斷變化的患者需求和不斷成長的需求。

2022 年 7 月,電子商務和數位行銷公司 RL Limited 與紐西蘭公司 AFT Pharmaceuticals 合作,透過線上市場天貓國際推出一系列 OTC 分銷管道。

目錄

第1章:非處方藥市場概述

  • 研究範圍
  • 市場預估年份

第 2 章:執行摘要

  • 市場片段
    • 非處方藥市場摘要(按類型)
    • 按配銷通路分類的非處方藥市場摘要
    • 按國家/地區分類的非處方藥市場摘要
    • 按地區分類的非處方藥市場摘要
  • 競爭洞察

第 3 章:非處方藥主要市場趨勢

  • 非處方藥市場促進因素
    • 市場促進因素的影響分析
  • 非處方藥市場限制
    • 市場限制影響分析
  • 非處方藥市場機會
  • 非處方藥市場未來趨勢

第 4 章:OTC 藥品產業研究

  • PEST分析
  • 波特五力分析
  • 成長前景圖
  • 規範架構分析

第 5 章:OTC 藥品市場:COVID-19 影響分析

  • COVID-19 之前的影響分析
  • COVID-19 後影響分析
    • 表現最佳的市場區隔
    • 邊際成長市場區隔
    • 最寬鬆的市場區隔
    • 邊際損失市場區隔

第 6 章:非處方藥市場格局

  • 2022 年非處方藥市佔率分析
  • 按主要製造商分類的故障數據
    • 既有參與者分析
    • 新興參與者分析

第 7 章:非處方藥市場 - 按類型

  • 概述
    • 按類型分類的細分市場佔有率分析
    • 止痛藥
    • 感冒和咳嗽的補救措施
    • 消化和腸道療法
    • 皮膚治療
    • 維生素和礦物質
    • 其他

第 8 章:非處方藥市場 - 按配銷通路

  • 概述
    • 按配銷通路分類的細分市場佔有率分析
    • 藥局和零售藥局
    • 醫院藥房
    • 網路藥局

第 9 章:非處方藥市場 - 按地理位置

  • 介紹
    • 按地理位置分類的細分市場佔有率分析
  • 北美洲
    • 概述
    • 北美非處方藥主要製造商
    • 北美市場規模和預測(按國家)
    • 北美市場規模和預測(按類型)
    • 北美市場規模和預測(按配銷通路)
    • 美國
    • 加拿大
  • 歐洲
    • 概述
    • 歐洲非處方藥主要製造商
    • 歐洲市場規模和預測(按國家)
    • 歐洲市場規模與預測(按類型)
    • 歐洲市場規模和預測(按配銷通路)
    • 德國
    • 義大利
    • 英國
    • 法國
    • 俄羅斯
    • 荷蘭
    • 瑞典
    • 波蘭
    • 歐洲其他地區
  • 亞太地區 (APAC)
    • 概述
    • 亞太地區非處方藥主要製造商
    • 亞太地區市場規模與預測(按國家)
    • 亞太地區市場規模與預測(按類型)
    • 亞太地區市場規模和預測(按配銷通路)
    • 印度
    • 中國
    • 日本
    • 韓國
    • 澳洲
    • 泰國
    • 印尼
    • 菲律賓
    • 亞太地區其他地區
  • 拉丁美洲
    • 概述
    • 拉丁美洲非處方藥主要製造商
    • 拉丁美洲市場規模與預測(按國家)
    • 拉丁美洲市場規模與預測(按類型)
    • 拉丁美洲市場規模和預測(按配銷通路)
    • 巴西
    • 墨西哥
    • 阿根廷
    • 哥倫比亞
    • 拉丁美洲其他地區
  • 中東和非洲
    • 概述
    • 中東和非洲非處方藥主要製造商
    • 中東和非洲市場規模及預測(按國家)
    • 中東和非洲市場規模及預測(按類型)
    • 中東和非洲市場規模及預測(按配銷通路)
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 以色列
    • 土耳其
    • 阿爾及利亞
    • 埃及
    • MEA 的其餘部分

第 10 章:主要供應商分析 - OTC 藥品產業

  • 競爭儀表板
  • 公司簡介
    • Johnson & Johnson Services Inc.
    • Bayer AG
    • Novartis AG
    • Sanofi SA
    • Pfizer
    • GlaxoSmithKline
    • Boehringer Ingelheim International GmbH
    • Reckitt Benckiser Group PLC
    • Takeda Pharmaceutical Company Ltd.
    • Perrigo Company plc

第 11 章:360 度分析師視角

第 12 章:附錄

  • 研究方法論
  • 參考
  • 縮寫
  • 免責聲明
  • 聯絡我們
Product Code: ANV1980

REPORT HIGHLIGHT

OTC Drugs Market size was valued at USD 162,794.3 Million in 2022, expanding at a CAGR of 5.0% from 2023 to 2030.

OTC or over the counter Distribution channels are pharmaceutical products that are considered safe to buy without the requirement of a prescription from a medical professional. These products are available in hospital pharmacies, medical stores, and sometimes even grocery shops, and are sold legally without any prescription. OTC medicines are used to treat some common symptoms, which include the common cold, body pain, allergies and flu, heartburn, acne, and other basic health problems.

OTC Drugs Market- Market Dynamics

The shift of manufacturers from prescription Distribution channels to OTC is expected to propel the market demand

One of the prominent trends in the market is the shift of manufacturers from prescription Distribution channels to OTC. Many manufacturing companies are switching their products from prescription to OTC. For instance, Bayer AG states in their 2019 annual report that, as part of its strategy, the company will change some of its prescriptive products suitable for self-care to OTC. This is anticipated to lead to a higher availability of these Distribution channels for various disease conditions in emerging and developed countries. Other trends in the market include the increasing number of private-label OTC products. The rise in online sales of the OTC products and tie-ups between private label manufacturers and e-commerce companies are developing new trends in the market. For instance, In September 2019, Dr. Reddy's Laboratories Ltd. announced the launch of an OTC Omeprazole Delayed-Release tablet in the U.S. market. These upcoming new trends will diversify market growth during the forecast period.

OTC Drugs Market- Key Insights

As per the analysis shared by our research analyst, the global OTC Drugs Market is estimated to grow annually at a CAGR of around 5.0% over the forecast period (2023-2030)

The OTC Drugs Market is projected to grow at a significant rate driven by shift of manufacturers from prescription Distribution channels to OTC

Based on Type, the cold & cough segment was predicted to show maximum market share in the year 2022

Based on Distribution channel, drug stores & retail pharmacies was the leading Segment in 2022

On the basis of region, North America was the leading revenue generator in 2022

OTC Drugs Market- Segmentation Analysis:

The Global OTC Drugs Market is segmented on the basis of Type, By Distribution channel, and Region.

On the basis of type, the market can be segmented into analgesics, cold & cough remedies, digestives & intestinal remedies, skin treatment, vitamins & minerals, and others. The cold & cough remedies segment is anticipated to dominate the market owing to the increasing occurrence of common colds and coughs among the population due to seasonal variation. According to the Centers for Disease Control and Prevention, cold and cough are the most common conditions in children below the age of 10 years and in geriatric populations above 65 years, which is leading to an increasing demand for therapeutic products.

Based on distribution channel, the market is segmented into drug stores & retail pharmacies, hospital pharmacies, and online pharmacies. The drug stores & retail pharmacies segment is projected to account for the largest market share during the forecast period owing to the increasing number of retail pharmacies offering OTC products and the rising patient preference for stores & retail pharmacies for these products. The hospital pharmacies segment accounts for the second-largest market share owing to increasing access to OTC Distribution channels and the availability of different products.

OTC Drugs Market- Geographical Insights

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

OTC Drugs Market- Competitive Landscape:

In the highly competitive OTC drug space, pharmaceutical companies are continually innovating to expand their product portfolios and enhance consumer access. Major players like Johnson & Johnson, Bayer AG, and Sanofi are strategically shifting from prescription drugs to over-the-counter offerings, thereby increasing the availability of self-care medications for various health conditions globally. Additionally, an emerging trend is the proliferation of private-label OTC products, driven by increasing online sales and partnerships between private label manufacturers and e-commerce giants. This trend is diversifying the market landscape and offering consumers a wider array of choices for self-medication. Recent collaborations and product launches, such as MCKESSON CORPORATION's introduction of the Foster & Thrive brand and RL Limited's partnership with AFT Pharmaceuticals for online OTC sales, reflect the industry's commitment to meeting evolving patient needs and capitalizing on the growing demand for accessible healthcare solutions.

Recent Developments:

In June 2023, MCKESSON CORPORATION, a diversified pharmaceutical company announced the launch of Foster & Thrive, a curated private brand of OTC health and wellness products in order to meet evolving patient needs and growing demand.

In July 2022, RL Limited, an e-commerce and digital marketing company, teamed up with AFT Pharmaceuticals, a New Zealand-based company, to launch a range of OTC Distribution channels through the online marketplace Tmall Global.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL OTC DRUGS MARKET KEY PLAYERS

  • Johnson & Johnson Services Inc.
  • Bayer AG
  • Novartis AG
  • Sanofi S.A
  • Pfizer
  • GlaxoSmithKline
  • Boehringer Ingelheim International GmbH
  • Reckitt Benckiser Group PLC
  • Takeda Pharmaceutical Company Ltd.
  • Perrigo Company plc

GLOBAL OTC DRUGS MARKET, BY TYPE

  • Analgesics
  • Cold & Cough Remedies
  • Digestives & Intestinal Remedies
  • Skin Treatment
  • Vitamins & Minerals
  • Others

GLOBAL OTC DRUGS MARKET, BY DISTRIBUTION CHANNEL

  • Drug stores & retail pharmacies
  • Hospital pharmacies
  • Online pharmacies

GLOBAL OTC DRUGS MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. OTC Drug Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. OTC Drug Market Snippet by Type
    • 2.1.2. OTC Drug Market Snippet by Distribution Channel
    • 2.1.3. OTC Drug Market Snippet by Country
    • 2.1.4. OTC Drug Market Snippet by Region
  • 2.2. Competitive Insights

3. OTC Drug Key Market Trends

  • 3.1. OTC Drug Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. OTC Drug Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. OTC Drug Market Opportunities
  • 3.4. OTC Drug Market Future Trends

4. OTC Drug Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. OTC Drug Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. OTC Drug Market Landscape

  • 6.1. OTC Drug Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. OTC Drug Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Analgesics
    • 7.1.3. Cold & Cough Remedies
    • 7.1.4. Digestives & Intestinal Remedies
    • 7.1.5. Skin Treatment
    • 7.1.6. Vitamins & Minerals
    • 7.1.7. Others

8. OTC Drug Market - By Distribution Channel

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Distribution Channel, 2022 & 2030 (%)
    • 8.1.2. Drug stores & retail pharmacies
    • 8.1.3. Hospital pharmacies
    • 8.1.4. Online pharmacies

9. OTC Drug Market- By Geography

  • 9.1. Introduction
    • 9.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 9.2. North America
    • 9.2.1. Overview
    • 9.2.2. OTC Drug Key Manufacturers in North America
    • 9.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.2.5. North America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.2.6. U.S.
      • 9.2.6.1. Overview
      • 9.2.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.6.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.6.4. U.S. Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.2.7. Canada
      • 9.2.7.1. Overview
      • 9.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.2.7.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.2.7.4. Canada Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.3. Europe
    • 9.3.1. Overview
    • 9.3.2. OTC Drug Key Manufacturers in Europe
    • 9.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.3.5. Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.6. Germany
      • 9.3.6.1. Overview
      • 9.3.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.6.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.6.4. Germany Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.7. Italy
      • 9.3.7.1. Overview
      • 9.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.7.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.7.4. Italy Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.8. United Kingdom
      • 9.3.8.1. Overview
      • 9.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.8.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.8.4. United Kingdom Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.9. France
      • 9.3.9.1. Overview
      • 9.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.9.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.9.4. France Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.10. Russia
      • 9.3.10.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.10.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.10.3. Russia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.11. Netherlands
      • 9.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.11.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.11.3. Netherlands Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.12. Sweden
      • 9.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.12.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.12.3. Sweden Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.13. Poland
      • 9.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.13.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.13.3. Poland Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.3.14. Rest of Europe
      • 9.3.14.1. Overview
      • 9.3.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.3.14.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.3.14.4. Rest of the Europe Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.4. Asia Pacific (APAC)
    • 9.4.1. Overview
    • 9.4.2. OTC Drug Key Manufacturers in Asia Pacific
    • 9.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.4.5. Asia Pacific Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.6. India
      • 9.4.6.1. Overview
      • 9.4.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.6.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.6.4. India Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.7. China
      • 9.4.7.1. Overview
      • 9.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.7.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.7.4. China Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.8. Japan
      • 9.4.8.1. Overview
      • 9.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.8.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.8.4. Japan Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.9. South Korea
      • 9.4.9.1. Overview
      • 9.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.9.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.9.4. South Korea Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.10. Australia
      • 9.4.10.1. Overview
      • 9.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.10.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.10.4. Australia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.11. Thailand
      • 9.4.11.1. Overview
      • 9.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.11.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.11.4. Thailand Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.12. Indonesia
      • 9.4.12.1. Overview
      • 9.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.12.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.12.4. Indonesia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.13. Philippines
      • 9.4.13.1. Overview
      • 9.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.13.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.13.4. Philippines Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.4.14. Rest of APAC
      • 9.4.14.1. Overview
      • 9.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.4.14.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.4.14.4. Rest of APAC Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.5. Latin America
    • 9.5.1. Overview
    • 9.5.2. OTC Drug Key Manufacturers in Latin America
    • 9.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.5.5. Latin America Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.6. Brazil
      • 9.5.6.1. Overview
      • 9.5.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.6.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.6.4. Brazil Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.7. Mexico
      • 9.5.7.1. Overview
      • 9.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.7.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.7.4. Mexico Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.8. Argentina
      • 9.5.8.1. Overview
      • 9.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.8.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.8.4. Argentina Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.9. Colombia
      • 9.5.9.1. Overview
      • 9.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.9.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.9.4. Colombia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.5.10. Rest of LATAM
      • 9.5.10.1. Overview
      • 9.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.5.10.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.5.10.4. Rest of LATAM Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
  • 9.6. Middle East and Africa
    • 9.6.1. Overview
    • 9.6.2. OTC Drug Key Manufacturers in Middle East and Africa
    • 9.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 9.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 9.6.5. Middle East and Africa Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.6. Saudi Arabia
      • 9.6.6.1. Overview
      • 9.6.6.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.6.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.6.4. Saudi Arabia Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.7. United Arab Emirates
      • 9.6.7.1. Overview
      • 9.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.7.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.7.4. United Arab Emirates Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.8. Israel
      • 9.6.8.1. Overview
      • 9.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.8.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.8.4. Israel Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.9. Turkey
      • 9.6.9.1. Overview
      • 9.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.9.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.9.4. Turkey Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.10. Algeria
      • 9.6.10.1. Overview
      • 9.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.10.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.10.4. Algeria Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.11. Egypt
      • 9.6.11.1. Overview
      • 9.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.11.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.11.4. Egypt Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)
    • 9.6.12. Rest of MEA
      • 9.6.12.1. Overview
      • 9.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 9.6.12.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 9.6.12.4. Rest of MEA Market Size and Forecast, By Distribution Channel, 2018 - 2030 (US$ Million)

10. Key Vendor Analysis- OTC Drug Industry

  • 10.1. Competitive Dashboard
  • 10.2. Company Profiles
    • 10.2.1. Johnson & Johnson Services Inc.
    • 10.2.2. Bayer AG
    • 10.2.3. Novartis AG
    • 10.2.4. Sanofi S.A
    • 10.2.5. Pfizer
    • 10.2.6. GlaxoSmithKline
    • 10.2.7. Boehringer Ingelheim International GmbH
    • 10.2.8. Reckitt Benckiser Group PLC
    • 10.2.9. Takeda Pharmaceutical Company Ltd.
    • 10.2.10. Perrigo Company plc

11. 360 Degree Analyst View

12. Appendix

  • 12.1. Research Methodology
  • 12.2. References
  • 12.3. Abbreviations
  • 12.4. Disclaimer
  • 12.5. Contact Us

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE OTC Drug Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global OTC Drug Market, by Type 2018-2030 (USD Million)
  • TABLE OTC Drug Market: Distribution Channel Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Distribution Channel
  • TABLE Global OTC Drug Market, by Distribution Channel 2018-2030 (USD Million)
  • TABLE OTC Drug Market: Regional snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global OTC Drug Market, by Region 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE North America OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa OTC Drug Market, by Distribution Channel, 2018-2030 (USD Million)